Eradication of Helicobacter pylori can be accurately confirmed 14 days after termination of triple therapy using a high-dose citric acid-based 13C urea breath test
- PMID: 16024926
- DOI: 10.1159/000087045
Eradication of Helicobacter pylori can be accurately confirmed 14 days after termination of triple therapy using a high-dose citric acid-based 13C urea breath test
Abstract
Background: Confirmation of Helicobacter pylori eradication by urea breath test (UBT) is currently performed 4-6 weeks after completion of therapy because of unacceptable false-negative results in UBTs performed earlier. Use of a high-dose citric acid test meal appears to enable accurate detection of H. pylori even during short term therapy with proton pump inhibitors.
Aim: To evaluate if use of a high dose citric acid (4.0 g) test meal can decrease the interval required for confirmation of eradication after triple therapy.
Methods: 233 patients positive for H. pylori were randomized to undergo UBT at 7 days or 14 days after triple therapy, and again at 6 weeks. The latter test was considered the gold standard test.
Results: The UBT performed 6 weeks after the end of treatment found that 79.9% were cured. The same test 7 days after therapy found false-negative detection of H. pylori in 7.3% patients compared to 3.2% patients examined after 14 days. The sensitivity, specificity, positive and negative predictive values and accuracy for evaluation on day 14 were 80, 100, 100, 96.3 and 96.7%, respectively.
Conclusions: High-dose citric acid-based UBT is a valid test for the assessment of H. pylori status 14 days after triple therapy. This may obviate the delay in instituting second-line eradication therapy, or further evaluation of the symptomatic patient unresponsive to therapy despite eradication.
Copyright (c) 2005 S. Karger AG, Basel.
Comment in
-
13C-urea breath test: further modification towards an unrestricted use.Digestion. 2005;71(4):206-7. doi: 10.1159/000087070. Epub 2005 Jul 13. Digestion. 2005. PMID: 16024925 No abstract available.
Similar articles
-
Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.Aliment Pharmacol Ther. 2008 Dec 1;28(11-12):1304-8. doi: 10.1111/j.1365-2036.2008.03846.x. Epub 2008 Sep 4. Aliment Pharmacol Ther. 2008. PMID: 18774949
-
Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting.Am J Gastroenterol. 1999 Aug;94(8):2100-4. doi: 10.1111/j.1572-0241.1999.01284.x. Am J Gastroenterol. 1999. PMID: 10445534
-
[13C]urea breath test to confirm eradication of Helicobacter pylori.Am J Gastroenterol. 1995 Feb;90(2):224-6. Am J Gastroenterol. 1995. PMID: 7847290
-
[13C-urea breath test].Nihon Rinsho. 2001 Feb;59(2):267-71. Nihon Rinsho. 2001. PMID: 11218396 Review. Japanese.
-
[The 13C-urea breath test efficacy in determining Helicobacter pylori eradication].Nihon Rinsho. 1999 Jan;57(1):93-6. Nihon Rinsho. 1999. PMID: 10036942 Review. Japanese.
Cited by
-
Evaluation of methods for H. pylori detection in PPI consumption using culture, rapid urease test and smear examination.Ann Transl Med. 2015 Jan;3(1):11. doi: 10.3978/j.issn.2305-5839.2014.11.16. Ann Transl Med. 2015. PMID: 25705643 Free PMC article.
-
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.World J Gastroenterol. 2014 Feb 14;20(6):1438-49. doi: 10.3748/wjg.v20.i6.1438. World J Gastroenterol. 2014. PMID: 24587620 Free PMC article. Review.
-
Effect of Vonoprazan, a Potassium-Competitive Acid Blocker, on the 13C-Urea Breath Test in Helicobacter pylori-Positive Patients.Dig Dis Sci. 2017 Mar;62(3):739-745. doi: 10.1007/s10620-016-4439-0. Epub 2017 Jan 12. Dig Dis Sci. 2017. PMID: 28083842 Clinical Trial.
-
Non-invasive diagnostic tests for Helicobacter pylori infection.Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2. Cochrane Database Syst Rev. 2018. PMID: 29543326 Free PMC article.
-
Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.Helicobacter. 2017 Jun;22(3):e12368. doi: 10.1111/hel.12368. Epub 2017 Jan 8. Helicobacter. 2017. PMID: 28066960 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical